Market Research Report: Health Care Originals, Inc.

Company Overview

• Name: Health Care Originals, Inc. (HCO)

• Mission of the Company: To provide better insight into respiratory diseases, allowing freedom and peace of mind. HCO aims to revolutionize the management of chronic respiratory diseases to improve the quality of life for sufferers and their caregivers.

• Founded By: Sharon Samjitsingh and her husband, Jared.

• Headquarters: Rochester, NY

• Key People:

• Sharon Samjitsingh, Co-Founder and Chief Executive Officer

• Cameron Jacox, Strategic Growth Advisor

• Number of Employees: No information is available.

• Revenue: No information is available.

• Known For: HCO is renowned for creating cardiopulmonary wearable systems that comprise both hardware and software, focusing specifically on managing chronic respiratory diseases such as asthma and COPD.

Products

ADAMM (Automated Device for Asthma Monitoring and Management)

• Description: The ADAMM series includes several configurations designed for different settings, including personal use, research, and health systems. The device is a small, flexible wearable patch that can be worn discreetly under clothing to monitor respiratory conditions.

• Key Features:

• Tracks coughing, respiration, presence of wheeze, temperature, heart rate, and activity level.

• Offers a journal function via pressing the wearable to record changes, feelings, or behaviors.

• Automated reporting and real-time notifications for users and caregivers.

• Can be integrated with mobile applications for enhanced data analysis and monitoring.

Nightingale Program

• Description: A digital health solution validated for its efficacy in managing chronic respiratory diseases.

• Key Features:

• Independently validated to significantly improve clinical outcomes in respiratory care.

• Employs artificial intelligence for data analysis and prediction of symptom exacerbation.

• Provides tools for health care systems to better manage asthma and COPD patients.

Recent Developments

• New Products Launched: No specific new product launches have been specified.

• Recent Developments:

• Independent Validation for Nightingale: In August 2024, HCO's Nightingale program received independent validation confirming its positive impact on clinical outcomes.

• Strategic Growth Advisor Appointment: In July 2023, Cameron Jacox was appointed as Strategic Growth Advisor to focus on scaling HCO's digital health initiatives.

• Partnerships:

• University of Alberta Collaboration: In August 2021, a partnership was formed to use the ADAMM device and AI to predict respiratory symptoms in chronic lung conditions.

• University of Montana Collaboration: In December 2019, HCO partnered with the University of Montana to pioneer solutions for chronic cough sufferers.

• Strategic Alliance with Healthport: In November 2018, a strategic alliance was formed to enhance the digital health landscape in Australia and New Zealand.

Additional Notes

• Focus on Respiratory Health: HCO’s work emphasizes that chronic respiratory conditions are under-served and requires more personalized approaches in treatment regimens.

• Innovation and Growth: The company has maintained steady growth through innovation, product development, and strategic partnerships, as highlighted by the involvement of industry figures like Dr. Bradford Berk and Eric Allyn.

• Global Health Challenges: With increasing numbers of people affected by respiratory conditions, HCO is poised to address these health challenges through its cutting-edge technologies and solutions.